Cabozantinib for Renal Cell Carcinoma: Current and Future Paradigms
Crossref DOI link: https://doi.org/10.1007/s11864-017-0444-6
Published Online: 2017-03-13
Published Print: 2017-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Abdelaziz, Ahmed
Vaishampayan, Ulka
License valid from 2017-03-01
